| For: | Ke M, Chong CM, Su H. Using induced pluripotent stem cells for modeling Parkinson’s disease. World J Stem Cells 2019; 11(9): 634-649 [PMID: 31616540 DOI: 10.4252/wjsc.v11.i9.634] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v11/i9/634.htm |
| Number | Citing Articles |
| 1 |
Minyoung Oh, Juhyeon Nam, Areum Baek, Ji-Hye Seo, Jung-Il Chae, Seo-Young Lee, Sun-Ku Chung, Byoung Chul Park, Sung Goo Park, Janghwan Kim, Young-Joo Jeon. Neuroprotective Effects of Licochalcone D in Oxidative-Stress-Induced Primitive Neural Stem Cells from Parkinson’s Disease Patient-Derived iPSCs. Biomedicines 2023; 11(1) doi: 10.3390/biomedicines11010228
|
| 2 |
Noura A A Ebrahim, Thoraya A Farghaly, Soliman Mehawed Abdellatif Soliman, Aya Arafat. Exercise with induced pluripotent stem cells enhances Wnt1-Lmx1a signaling and dopaminergic neurogenesis to alleviate Parkinsonian symptoms. World Journal of Stem Cells 2025; 17(12): 113924 doi: 10.4252/wjsc.v17.i12.113924
|
| 3 |
Jiabin Liu, Jieqiong Tan, Beisha Tang, Jifeng Guo. Unveiling the role of iPLA2β in neurodegeneration: From molecular mechanisms to advanced therapies. Pharmacological Research 2024; 202 doi: 10.1016/j.phrs.2024.107114
|
| 4 |
Kaavya Jayaramayya, Mahalaxmi Iyer, Dhivya Venkatesan, Venkatesh Balasubramanian, Arul Narayanasamy, Mohana Devi Subramaniam, Ssang Goo Cho, Balachandar Vellingiri. Unraveling correlative roles of dopamine transporter (DAT) and Parkin in Parkinson’s disease (PD) – A road to discovery?. Brain Research Bulletin 2020; 157 doi: 10.1016/j.brainresbull.2020.02.001
|
| 5 |
S. A. Antonov, E. V. Novosadova. Current State-of-the-Art and Unresolved Problems in Using Human Induced Pluripotent Stem Cell-Derived Dopamine Neurons for Parkinson’s Disease Drug Development. International Journal of Molecular Sciences 2021; 22(7) doi: 10.3390/ijms22073381
|
| 6 |
Koyel Kar. Genome Editing for Neurodegenerative Diseases. 2025; doi: 10.1016/B978-0-443-23826-0.00009-X
|
| 7 |
Pia Rivetti di Val Cervo, Dario Besusso, Paola Conforti, Elena Cattaneo. hiPSCs for predictive modelling of neurodegenerative diseases: dreaming the possible. Nature Reviews Neurology 2021; 17(6) doi: 10.1038/s41582-021-00465-0
|
| 8 |
A. Katherine Hatstat, Michael D. Pupi, Michaela C. Reinhart, Dewey G. McCafferty. Small Molecule Improvement of Trafficking Defects in Models of Neurodegeneration. ACS Chemical Neuroscience 2021; 12(21) doi: 10.1021/acschemneuro.1c00524
|
| 9 |
Elena Coccia, Tim Ahfeldt. Towards physiologically relevant human pluripotent stem cell (hPSC) models of Parkinson’s disease. Stem Cell Research & Therapy 2021; 12(1) doi: 10.1186/s13287-021-02326-5
|
| 10 |
Julian Krauskopf, Kristel Eggermont, Rodrigo Furtado Madeiro Da Costa, Sacha Bohler, Duncan Hauser, Florian Caiment, Theo M. de Kok, Catherine Verfaillie, Jos C. Kleinjans. Transcriptomics analysis of human iPSC-derived dopaminergic neurons reveals a novel model for sporadic Parkinson’s disease. Molecular Psychiatry 2022; 27(10) doi: 10.1038/s41380-022-01663-y
|
| 11 |
Shiyao Hua, Jiayue Liu, Liang Zou, Peng Li. Handbook of Dietary Flavonoids. 2023; doi: 10.1007/978-3-030-94753-8_27-1
|
| 12 |
V. Valadez-Barba, K. Juárez-Navarro, E. Padilla-Camberos, N.F. Díaz, J.R. Guerra-Mora, N.E. Díaz-Martínez. Enfermedad de Parkinson: actualización de estudios preclínicos con el uso de células troncales pluripotentes inducidas. Neurología 2023; 38(9) doi: 10.1016/j.nrl.2021.01.005
|
| 13 |
Tuuli-Maria Sonninen, Lidiia Plotnikova, Nihay Laham-Karam, Gundars Goldsteins, Jari Koistinaho, Šárka Lehtonen. iPSCs for Modeling Central Nervous System Disorders. 2021; doi: 10.1016/B978-0-323-85764-2.00009-0
|
| 14 |
Niloufar Yousefi, Shahla Abdollahii, Mohammad Amin Jadidi Kouhbanani, Ali Hassanzadeh. Induced pluripotent stem cells (iPSCs) as game‐changing tools in the treatment of neurodegenerative disease: Mirage or reality?. Journal of Cellular Physiology 2020; 235(12) doi: 10.1002/jcp.29800
|
| 15 |
Rosalie Elvira, Eng King Tan, Zhi Dong Zhou. Three-dimensional midbrain organoids: a next-generation tool for Parkinson’s disease modelling and drug discovery. Stem Cell Research & Therapy 2025; 16(1) doi: 10.1186/s13287-025-04660-4
|
| 16 |
Ying Zhang, Xinyang Xie, Jiangnan Hu, Kazi Sabrina Afreen, Chun-Li Zhang, Qichuan Zhuge, Jianjing Yang. Prospects of Directly Reprogrammed Adult Human Neurons for Neurodegenerative Disease Modeling and Drug Discovery: iN vs. iPSCs Models. Frontiers in Neuroscience 2020; 14 doi: 10.3389/fnins.2020.546484
|
| 17 |
Jiajia Xu, Yangyang Li, Huan Zhu, Wenyu Wu, Yumeng Liu, Yu Guo, Weijun Guan, Changqing Liu, Caiyun Ma. Therapeutic function of a novel rat induced pluripotent stem cell line in a 6‑OHDA‑induced rat model of Parkinson's disease. International Journal of Molecular Medicine 2022; 50(6) doi: 10.3892/ijmm.2022.5196
|
| 18 |
|
| 19 |
Ainsley Mike Antao, Janardhan Keshav Karapurkar, Dong Ryul Lee, Kye-Seong Kim, Suresh Ramakrishna. Disease modeling and stem cell immunoengineering in regenerative medicine using CRISPR/Cas9 systems. Computational and Structural Biotechnology Journal 2020; 18 doi: 10.1016/j.csbj.2020.11.026
|
| 20 |
David Arango, Amaury Bittar, Natalia P. Esmeral, Camila Ocasión, Carolina Muñoz-Camargo, Juan C. Cruz, Luis H. Reyes, Natasha I. Bloch. Understanding the Potential of Genome Editing in Parkinson’s Disease. International Journal of Molecular Sciences 2021; 22(17) doi: 10.3390/ijms22179241
|
| 21 |
Tirthankar Sen, Rajkumar P. Thummer. CRISPR and iPSCs: Recent Developments and Future Perspectives in Neurodegenerative Disease Modelling, Research, and Therapeutics. Neurotoxicity Research 2022; 40(5) doi: 10.1007/s12640-022-00564-w
|
| 22 |
Yu Guo, Yuan-Yuan Wang, Ting-Ting Sun, Jia-Jia Xu, Pan Yang, Cai-Yun Ma, Wei-Jun Guan, Chun-Jing Wang, Gao-Feng Liu, Chang-Qing Liu. Neural progenitor cells derived from fibroblasts induced by small molecule compounds under hypoxia for treatment of Parkinson’s disease in rats. Neural Regeneration Research 2023; 18(5) doi: 10.4103/1673-5374.355820
|
| 23 |
Joo-Eun Lee, Hyuna Sim, Hee Min Yoo, Minhyung Lee, Aruem Baek, Young-Joo Jeon, Kang-Sik Seo, Mi-Young Son, Joo Seog Yoon, Janghwan Kim. Neuroprotective Effects of Cryptotanshinone in a Direct Reprogramming Model of Parkinson’s Disease. Molecules 2020; 25(16) doi: 10.3390/molecules25163602
|
| 24 |
Babak Arjmand, Shayesteh Kokabi-Hamidpour, Hamid Reza Aghayan, Sepideh Alavi-Moghadam, Rasta Arjmand, Mostafa Rezaei-Tavirani, Parisa Goodarzi, Ensieh Nasli-Esfahani, Mohsen Nikandish. . Methods in Molecular Biology 2023; doi: 10.1007/7651_2022_473
|
| 25 |
Yiran Xu, Shuxia Wang, Ping Zhu. Advances in the Application of Induced Pluripotent Stem Cells in Alzheimer’s Disease and Parkinson's Disease. Current Stem Cell Research & Therapy 2023; 18(2) doi: 10.2174/1574888X17666220426114050
|
| 26 |
V. Valadez-Barba, K. Juárez-Navarro, E. Padilla-Camberos, N.F. Díaz, J.R. Guerra-Mora, N.E. Díaz-Martínez. Parkinson’s disease: an update on preclinical studies of induced pluripotent stem cells. Neurología (English Edition) 2023; 38(9) doi: 10.1016/j.nrleng.2023.10.004
|
| 27 |
Nimmy Varghese, Amandine Grimm, M. Zameel Cader, Anne Eckert. From Young to Old: Mimicking Neuronal Aging in Directly Converted Neurons from Young Donors. Cells 2024; 13(15) doi: 10.3390/cells13151260
|